Literature DB >> 28874589

Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release.

Yalikun Suofu1, Wei Li1,2, Frédéric G Jean-Alphonse3, Jiaoying Jia1,4, Nicolas K Khattar1, Jiatong Li1,2, Sergei V Baranov1, Daniela Leronni1, Amanda C Mihalik1, Yanqing He1,4, Erika Cecon5,6,7, Vanessa L Wehbi3, JinHo Kim1, Brianna E Heath1, Oxana V Baranova1, Xiaomin Wang1, Matthew J Gable1, Eric S Kretz1, Giulietta Di Benedetto8, Timothy R Lezon9,10, Lisa M Ferrando1, Timothy M Larkin1, Mara Sullivan11, Svitlana Yablonska1, Jingjing Wang1,2, M Beth Minnigh12, Gérald Guillaumet13, Franck Suzenet13, R Mark Richardson14, Samuel M Poloyac12, Donna B Stolz11, Ralf Jockers5,6,7, Paula A Witt-Enderby15, Diane L Carlisle1, Jean-Pierre Vilardaga16, Robert M Friedlander17.   

Abstract

G protein-coupled receptors (GPCRs) are classically characterized as cell-surface receptors transmitting extracellular signals into cells. Here we show that central components of a GPCR signaling system comprised of the melatonin type 1 receptor (MT1), its associated G protein, and β-arrestins are on and within neuronal mitochondria. We discovered that the ligand melatonin is exclusively synthesized in the mitochondrial matrix and released by the organelle activating the mitochondrial MT1 signal-transduction pathway inhibiting stress-mediated cytochrome c release and caspase activation. These findings coupled with our observation that mitochondrial MT1 overexpression reduces ischemic brain injury in mice delineate a mitochondrial GPCR mechanism contributing to the neuroprotective action of melatonin. We propose a new term, "automitocrine," analogous to "autocrine" when a similar phenomenon occurs at the cellular level, to describe this unexpected intracellular organelle ligand-receptor pathway that opens a new research avenue investigating mitochondrial GPCR biology.

Entities:  

Keywords:  G protein-coupled receptor; ischemia; melatonin; mitochondria; neuroprotection

Mesh:

Substances:

Year:  2017        PMID: 28874589      PMCID: PMC5617277          DOI: 10.1073/pnas.1705768114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide.

Authors:  B Poeggeler; L Miravalle; M G Zagorski; T Wisniewski; Y J Chyan; Y Zhang; H Shao; T Bryant-Thomas; R Vidal; B Frangione; J Ghiso; M A Pappolla
Journal:  Biochemistry       Date:  2001-12-11       Impact factor: 3.162

2.  Mitochondrial CB₁ receptors regulate neuronal energy metabolism.

Authors:  Giovanni Bénard; Federico Massa; Nagore Puente; Joana Lourenço; Luigi Bellocchio; Edgar Soria-Gómez; Isabel Matias; Anna Delamarre; Mathilde Metna-Laurent; Astrid Cannich; Etienne Hebert-Chatelain; Christophe Mulle; Silvia Ortega-Gutiérrez; Mar Martín-Fontecha; Matthias Klugmann; Stephan Guggenhuber; Beat Lutz; Jürg Gertsch; Francis Chaouloff; María Luz López-Rodríguez; Pedro Grandes; Rodrigue Rossignol; Giovanni Marsicano
Journal:  Nat Neurosci       Date:  2012-03-04       Impact factor: 24.884

3.  Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations.

Authors:  Carmen Venegas; José A García; Germaine Escames; Francisco Ortiz; Ana López; Carolina Doerrier; Laura García-Corzo; Luis C López; Russel J Reiter; Darío Acuña-Castroviejo
Journal:  J Pineal Res       Date:  2011-09-02       Impact factor: 13.007

4.  Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.

Authors:  H Hara; R M Friedlander; V Gagliardini; C Ayata; K Fink; Z Huang; M Shimizu-Sasamata; J Yuan; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 5.  Endosomal generation of cAMP in GPCR signaling.

Authors:  Jean-Pierre Vilardaga; Frederic G Jean-Alphonse; Thomas J Gardella
Journal:  Nat Chem Biol       Date:  2014-09       Impact factor: 15.040

6.  Melatonin decreases production of hydroxyl radical during cerebral ischemia-reperfusion.

Authors:  X J Li; L M Zhang; J Gu; A Z Zhang; F Y Sun
Journal:  Zhongguo Yao Li Xue Bao       Date:  1997-09

7.  Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats.

Authors:  K Sinha; M N Degaonkar; N R Jagannathan; Y K Gupta
Journal:  Eur J Pharmacol       Date:  2001-10-05       Impact factor: 4.432

8.  Huntingtin inhibits caspase-3 activation.

Authors:  Yu Zhang; Blair R Leavitt; Jeremy M van Raamsdonk; Ioannis Dragatsis; Dan Goldowitz; Marcy E MacDonald; Michael R Hayden; Robert M Friedlander
Journal:  EMBO J       Date:  2006-11-23       Impact factor: 11.598

9.  Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.

Authors:  Yi Zhang; Anna Cook; Jinho Kim; Sergei V Baranov; Jiying Jiang; Karen Smith; Kerry Cormier; Erik Bennett; Robert P Browser; Arthur L Day; Diane L Carlisle; Robert J Ferrante; Xin Wang; Robert M Friedlander
Journal:  Neurobiol Dis       Date:  2013-03-26       Impact factor: 5.996

10.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.

Authors:  Sébastien Ferrandon; Timothy N Feinstein; Marian Castro; Bin Wang; Richard Bouley; John T Potts; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2009-08-23       Impact factor: 15.040

View more
  100 in total

1.  Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs.

Authors:  Mahmud Hasan; Mohamed Akmal Marzouk; Saugat Adhikari; Thomas D Wright; Benton P Miller; Margarite D Matossian; Steven Elliott; Maryl Wright; Madlin Alzoubi; Bridgette M Collins-Burow; Matthew E Burow; Ulrike Holzgrabe; Darius P Zlotos; Robert E Stratford; Paula A Witt-Enderby
Journal:  Mol Pharmacol       Date:  2019-06-20       Impact factor: 4.436

2.  Intracellular GPCRs Play Key Roles in Synaptic Plasticity.

Authors:  Yuh-Jiin I Jong; Steven K Harmon; Karen L O'Malley
Journal:  ACS Chem Neurosci       Date:  2018-02-16       Impact factor: 4.418

Review 3.  Mood-related central and peripheral clocks.

Authors:  Kyle D Ketchesin; Darius Becker-Krail; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2018-11-29       Impact factor: 3.386

Review 4.  New Insights in Cannabinoid Receptor Structure and Signaling.

Authors:  Lingyan Ye; Zheng Cao; Weiwei Wang; Naiming Zhou
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 5.  Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions.

Authors:  Andrzej T Slominski; Ruediger Hardeland; Michal A Zmijewski; Radomir M Slominski; Russel J Reiter; Ralf Paus
Journal:  J Invest Dermatol       Date:  2018-02-07       Impact factor: 8.551

Review 6.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

7.  An improved method for isolation of mitochondria from cell lines that enables reconstitution of calcium-dependent processes.

Authors:  Masaaki Ishii; Gyda Beeson; Craig Beeson; Bärbel Rohrer
Journal:  Anal Biochem       Date:  2019-04-22       Impact factor: 3.365

8.  Reply to Ahluwalia et al.: Contributions of melatonin receptors are tissue-dependent.

Authors:  Yalikun Suofu; Diane L Carlisle; Jean-Pierre Vilardaga; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-09       Impact factor: 11.205

9.  Melatonin signaling in mitochondria extends beyond neurons and neuroprotection: Implications for angiogenesis and cardio/gastroprotection.

Authors:  Amrita Ahluwalia; Iwona M Brzozowska; Neil Hoa; Michael K Jones; Andrzej S Tarnawski
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-09       Impact factor: 11.205

Review 10.  Melatonin and cannabinoids: mitochondrial-targeted molecules that may reduce inflammaging in neurodegenerative diseases.

Authors:  Sebastián García; Virna Margarita Martín Giménez; Feres José Mocayar Marón; Russel J Reiter; Walter Manucha
Journal:  Histol Histopathol       Date:  2020-03-10       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.